DarioHealth Q4 EPS $(0.41) Beats $(0.54) Estimate
Portfolio Pulse from Benzinga Newsdesk
DarioHealth (NASDAQ:DRIO) reported Q4 losses of $(0.41) per share, surpassing the analyst consensus estimate of $(0.54) by 24.07%. This represents a 19.61% improvement over the same period last year.
March 28, 2024 | 10:43 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DarioHealth reported a smaller loss than expected in Q4, with EPS of $(0.41) beating the $(0.54) estimate, indicating a 19.61% year-over-year improvement.
Beating earnings estimates typically leads to positive investor sentiment and can result in a short-term stock price increase. The significant improvement over the previous year's losses further strengthens the positive outlook for DarioHealth.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100